All News #Library
Biotech
Vima Therapeutics Doses First Patient in Phase 2 Dystonia Trial
11 Mar 2026 //
GLOBENEWSWIRE
Vima Therapeutics Launches First Oral Therapy for Dystonia
29 May 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support